Jack O'Brien
imjackobrien.bsky.social
Jack O'Brien
@imjackobrien.bsky.social
Executive Editor at MM+M, an award-winning Haymarket Media publication that produces timely, balanced, original editorial content for an audience of leaders in pharmaceutical and healthcare marketing.

https://www.mmm-online.com/author/jack-obrien/
Kyle Long, a former NFL star and current CBS Sports analyst, is participating in Johnson & Johnson’s Generation Fine initiative.

www.mmm-online.com/news/former-...
Former NFL star Kyle Long guards his mental health as part of J&J's Generation Fine
Kyle Long, a former NFL star and current CBS Sports analyst, is participating in Johnson & Johnson’s Generation Fine initiative.
www.mmm-online.com
September 10, 2026 at 5:50 PM
Pharma brands were among the top advertisers during the 2025-26 NFL regular season, according to a report released by EDO.

The TV outcomes company found that three of the top five regular-season advertisers — including the top two — were pharma brands.

www.mmm-online.com/news/pharma-...
‘A great year for the pharma in the NFL’: EDO delivers 2025–26 season insights
EDO’s report found that ads from pharma brands were 95% more effective on a per-impression engagement basis during regular-season NFL games than they were during primetime broadcast and cable.
www.mmm-online.com
September 3, 2026 at 8:09 PM
I got to sit down down with Mick Ebeling, founder of Not Impossible Labs, CMI Media Group CEO Susan Dorfman and Chris Fox, VP of marketing at Cleveland Diagnostics.

www.mmm-online.com/podcasts/wha...
What to expect at 2026 CMI Agility in Philadelphia
Executive editor Jack O’Brien sits down with Mick Ebeling, founder of Not Impossible Labs, CMI Media Group CEO Susan Dorfman and Chris Fox, VP of marketing at Cleveland Diagnostics.
www.mmm-online.com
September 2, 2026 at 7:34 PM
Snapchat adds pharma ad disclaimer links: What medical marketers need to know.

Snapchat’s new features are intended to curry favor with pharma advertisers, establishing the social media app as more flexible and compliance friendly.

www.mmm-online.com/news/snapcha...
Snapchat adds pharma ad disclaimer links: What medical marketers need to know.
Snapchat’s new features are intended to curry favor with pharma advertisers, establishing the social media app as more flexible and compliance friendly.
www.mmm-online.com
August 27, 2026 at 6:27 PM
DeVito/Verdi co-founder Ellis Verdi is a classic New York adman with more than a few dozen stories to tell from his more than 45 years in the industry.

www.mmm-online.com/podcasts/ell...
Ellis Verdi on hospital marketing, Hillary's 2000 campaign and tropical fish
DeVito/Verdi co-founder Ellis Verdi is a classic New York adman with more than a few dozen stories to tell from his more than 45 years in the industry.
www.mmm-online.com
August 19, 2026 at 8:12 PM
Lucid Group announced Eric Muller has joined the agency as CEO this morning.

The U.K.-based parent company of 2026 MM+M Agency 100 honoree Lucid announced Muller will succeed DiD Agency founder Rick Sannem, who will transition to strategic advisor to the board.

www.mmm-online.com/news/lucid-e...?
Lucid appoints former Publicis Health COO Eric Muller as CEO
Muller succeeds DiD Agency founder Rick Sannem, who will transition to strategic advisor to the board.
www.mmm-online.com
August 19, 2026 at 2:12 PM
MM+M says goodbye (again) to editorial fellow Lola Offenback following her second stint as our summer intern.

We also talk about the proposed changes to the vaccine schedule and the illogical policy messaging from Trump administration health officials.

www.mmm-online.com/podcasts/mmm...
MM+M summer intern Lola Offenback's (second) exit interview
MM+M says goodbye (again) to editorial fellow Lola Offenback following her second stint as our summer intern.
www.mmm-online.com
August 12, 2026 at 3:12 PM
GLP-1 marketing growth, biosimilar competition & China top pharma’s Q2 earnings

The Q2 pharma earnings reports paint a picture of an industry willing to continue to spend where they can boost the topline while also reprioritizing efforts that are less profitable.

www.mmm-online.com/news/glp-1-b...
GLP-1 marketing growth, biosimilar competition and China top pharma’s Q2 earnings
Broadly speaking, the Q2 pharma earnings reports paint a picture of an industry willing to continue to spend where they can boost the topline while also reprioritizing efforts that are less profitable...
www.mmm-online.com
August 11, 2026 at 7:13 PM
Don't miss out on the premier event of the year for AI strategy and innovation — AI Deciphered!

Join us on Thursday, November 12 for the ultimate summit for anyone serious about elevating their brand and business in today's ever-evolving tech ecosystem.

Secure your seat here: lnkd.in/gZm3jvDd
July 30, 2026 at 2:46 PM
MM+M opened the nomination period for its Best Places to Work program!

All Best Places to Work survey responses must be finalized and submitted by September 11 at 11:59 p.m. ET. No extensions will be granted.

www.mmm-online.com/news/mmm-lau...?
MM+M launches 2026 Best Places to Work survey
In its ninth year, the annual honorarium solicits submissions to determine which medical marketing workplaces are top-notch and what factors drive their respective successes.
www.mmm-online.com
July 29, 2026 at 4:48 PM
Two MM+M Agency 100 honorees, one deal:

CG Life is acquiring The Considered, in a bid to compete more directly with larger medical marketing agency networks.

The Considered+AI founder David Hunt will join CG Life’s board and retain a major ownership stake.

www.mmm-online.com/news/cg-life...
CG Life scoops up AI-native agency The Considered+AI
The deal features two MM+M Agency 100 honorees and combines CG Life’s scientific expertise with The Considered’s AI-native model as the pair look to win business from larger competitors.
www.mmm-online.com
July 28, 2026 at 1:20 PM
Havas Lynx has undergone a major leadership change, with Havas Lynx UK CEO Claire Knapp expanding her remit to oversee Havas Lynx New York.

Also, Joanna Ruiz and Megan Skelly have departed Havas Lynx, while Bruno Rebelo has joined as chief creative officer.

www.mmm-online.com/news/havas-l...
Havas Lynx UK CEO Claire Knapp adds Havas Lynx New York to remit in C-suite shakeup
As part of the leadership changes, Joanna Ruiz and Megan Skelly have departed Havas Lynx, while Bruno Rebelo has joined as chief creative officer.
www.mmm-online.com
July 27, 2026 at 2:41 PM
In a special episode of the podcast, I got to chat with 2026 Pro Football Hall of Fame inductee Drew Brees about how he got involved with ARS Pharmaceuticals on its Neffy awareness campaign.

www.mmm-online.com/podcasts/nfl...
NFL legend Drew Brees huddles with ARS Pharmaceuticals for Neffy campaign
Super Bowl-winning quarterback and 2026 Pro Football Hall of Fame inductee Drew Brees talks about participating in an awareness campaign to promote ARS Pharmaceuticals’ emergency allergy spray, Neffy.
www.mmm-online.com
July 23, 2026 at 6:42 PM
Novartis’ chief corporate affairs officer Michelle Weese discusses the drugmaker’s history, how it is recognizing its 30 years in business and what we can expect as it relates to marketing in the months and years ahead.

www.mmm-online.com/podcasts/nov...
Novartis going on 30: Inside the Swiss pharma giant's corporate brand evolution
Novartis’ chief corporate affairs officer Michelle Weese discusses the drugmaker’s history, how it is recognizing its 30 years in business and what we can expect as it relates to marketing in the mont...
www.mmm-online.com
July 22, 2026 at 6:34 PM
All eyes are on Spain and Argentina as they compete in the FIFA World Cup final on Sunday.

As such, this week's episode of The MM+M Podcast is focused on the beautiful game and the health brands who have marketed throughout the five week tournament.

www.mmm-online.com/podcasts/hea...
Health brands take the pitch at the 2026 FIFA World Cup: Where the world comes to play
Leaders from Hackensack Meridian Health and Cologuard discuss their marketing efforts coinciding with the 2026 FIFA World Cup.
www.mmm-online.com
July 16, 2026 at 6:07 PM
We're 78 days out from the 2026 MM+M Awards and have the official shortlist for your viewing pleasure!

In its 23rd year, the medical marketing industry’s top awards program returns with new categories, including a leadership award honoring the brand’s founder.

www.mmm-online.com/news/mmm-unv...
MM+M unveils its 2026 Awards finalists
The MM+M Awards will be handed out at a gala event scheduled for October 1 at New York City’s Cipriani Wall Street.
www.mmm-online.com
July 15, 2026 at 2:26 PM
Andrea Lillis, SVP and executive creative director of Klick Health, joins the podcast this week to offer us an inside look of her work as a Pharma Lions juror, detail her time celebrating Klick’s big wins and outline what comes next for the Toronto-based agency.

www.mmm-online.com/podcasts/a-d...
A double click on Klick: Cannes, Oxford PharmaGenesis and A100
Andrea Lillis, SVP and executive creative director of Klick Health, North America, offers us an inside look of her work as a Pharma Lions juror, details her time celebrating Klick’s big wins and outli...
www.mmm-online.com
July 8, 2026 at 7:25 PM
It's great to have Avalere Health CEO Amar Urhekar back on the MM+M Podcast alongside his creative chief TJ Cimfel.

www.mmm-online.com/news/avalere...
Avalere Health delves into a multimedia cancer anthology while ViiV boosts PrEP during Pride
We’re joined by leaders from Avalere Health and ViiV Healthcare for a pair of conversations about cancer care and PrEP, respectively.
www.mmm-online.com
June 17, 2026 at 6:31 PM
Shortly after the 2026 MM+M Agency 100 launched, I huddled with Jameson Fleming, Lecia Bushak, Steve Madden and Bella Czajkowski to dig into the medical marketing firms we’ve been interviewing, writing and reporting on over the past five months.

www.mmm-online.com/podcasts/the...
The 2026 MM+M Agency 100, explained
The MM+M editorial staff unveils the 2026 Agency 100 and reflects on the trendlines observed over five months of reporting.
www.mmm-online.com
June 10, 2026 at 5:30 PM
The 2026 MM+M 100 is here -- bigger and better than ever!

Building off of our Neal Award-winning work, we expanded the project with the Power Partners lists and the introduction of an AI-powered chatbot to assist viewers through all of the data and insights.

www.mmm-online.com/2026-agency-...
Agency 100 Landing Page
www.mmm-online.com
June 9, 2026 at 7:57 PM
I can finally stop playing this silly game.
June 8, 2026 at 2:25 PM
For the first episode of May, which is Mental Health Awareness Month, we're joined by JED CEO John MacPhee and AFSP CEO Bob Gebbia.

The pair underline the reasoning for the merger and medical where marketers can improve messaging around mental health.

www.mmm-online.com/podcasts/int...
Introducing the largest suicide prevention nonprofit
To recognize the start of Mental Health Awareness Month, we’re joined by JED CEO John MacPhee and AFSP CEO Bob Gebbia.
www.mmm-online.com
May 6, 2026 at 2:00 PM
Weeks after AbbVie led off the season with its MLB partnership, Merck is stepping up to the plate with its own baseball-themed effort.

The pharma giant and WomenHeart launched Playing with Heart, a collaborative initiative featuring nine MLB teams.

www.mmm-online.com/news/why-mer...
Why Merck expanded its heart health mission with 9 MLB teams
Merck is tapping a number of baseball ambassadors to support its cardiovascular awareness push, including former World Series champion Geoff Blum.
www.mmm-online.com
May 4, 2026 at 8:56 PM
Personal news...

Just over four years after joining MM+M, I’m thrilled to be elevated to Executive Editor!

I'm so excited to helm a newsroom that produces such incisive, quality, award-winning news and analysis for our audience of medical marketing leaders.

www.mmm-online.com/news/mmm-ele...
MM+M elevates Jack O’Brien to executive editor
O’Brien joined the publication in April 2022 as digital editor and has served as senior editor and managing editor over the ensuing years.
www.mmm-online.com
April 30, 2026 at 2:13 PM
The 4/8 letter issued by the FDA to Pfizer over misleading advertising of its cancer drug Adcetris on Facebook served as a wakeup call for the medical marketing industry.

Now, pharma brands are well-advised to reevaluate their approach to social media marketing in the face of heightened scrutiny.
April 23, 2026 at 8:02 PM